Pharmaceutical ophthalmic compositions and uses thereof

JP2024544393APending Publication Date: 2024-11-29AERIE PHARMACEUTICALS INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2024535940
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-17
Filing Date
2022-12-16
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Current treatments for dry eye syndrome, such as artificial tears and corticosteroids, have limitations in efficacy and toxicity, and there is a need for pharmaceutical ophthalmic compositions that stabilize active ingredients like WS-12 to maximize their pharmaceutical activity while avoiding preservatives that can harm the eye.

Method used

Pharmaceutical ophthalmic compositions containing 0.0005% to 0.01% (1R,2S,5R)-2-isopropyl-N-(4-methoxyphenyl)-5-methylcyclohexane-1-carboxamide (WS-12) with solubilizers, viscosity modifiers, buffers, and tonicity agents, formulated to maintain stability and bioavailability, and packaged to protect against environmental factors.

Benefits of technology

The compositions effectively treat dry eye symptoms by increasing tear production, reducing discomfort, and maintaining WS-12 stability during storage, even at ambient temperatures, without the need for refrigeration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024544393000015
    Figure 2024544393000015
  • Figure 2024544393000016
    Figure 2024544393000016
  • Figure 2024544393000017
    Figure 2024544393000017
Patent Text Reader

Abstract

Provided herein are pharmaceutical ophthalmic compositions comprising (1R,2S,5R)-2-isopropyl-N-(4-methoxyphenyl)-5-methylcyclohexane-1-carboxamide (WS-12) for effectively treating dry eye in a subject in need thereof, effectively reducing dry eye in a subject in need thereof, effectively reducing the likelihood of dry eye in a subject in need thereof, or treating, preventing or ameliorating the signs or symptoms of dry eye in a subject in need thereof.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Chroman derivative-containing eye drop

    JP1999130675A

  • Ophthalmic composition with regulated viscosity

    JP2008195720A

  • Pharmaceutical composition

    JP2011213667A

  • Plastic oil and fat composition and food to which plastic oil and fat composition is added

    JP2016131559A

  • Ophthalmic composition for treating dry eye and symptoms thereof

    US20200306218A1